IMPACT Trial: Intervention to iMProve AdherenCe equitably
Sponsor: |
NIH |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAT8817 |
Contact: |
Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu |
Many patients with breast cancer, who also take medicine to prevent heart disease such as a blood pressure medicine or a cholesterol medicine, experience frustration with the large number and difficult scheduling of their medications, known as pill burden. This study will help us find out how much pill burden exists in subjects with cancer at various stages, and how this intervention can help. Results of this study may help us figure out the best way to help patients manage their medications in the future.
Investigator
Dawn Hershman, MD
Have you been diagnosed with breast cancer? |
Yes |
No |
Do you speak English? |
Yes |
No |